{"transactions":[{"id":4267680,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":174705,"kind":"person","name":"Lorenzo Jennifer","position":1,"cik":"0001697285","reported_name":"Lorenzo Jennifer","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Shareholder"}},{"id":174706,"kind":"organization","name":"GJG Life Sciences, LLC","position":2,"cik":"0001582638","reported_name":"GJG Life Sciences, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Shareholder"}},{"id":174707,"kind":"organization","name":"GJG Capital, LLC","position":3,"cik":"0001698996","reported_name":"GJG Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Shareholder"}}],"security":"Common Stock","published_at":"2017-07-03T14:02:28.000Z","date":"2017-06-28","kind":"other","acquired":true,"shares":1565333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 29, 2017, GJG Life Sciences, LLC distributed to its Members, pro-rata without consideration, 10,496,760 shares of Matinas common stock. Of such shares, 8,931,427 shares were distributed to the Class A Members and the remaining 1,565,333 shares were distributed to the reporting person, the Managing Member of the Class B Member, GJG Capital, LLC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 29, 2017, GJG Life Sciences, LLC distributed to its Members, pro-rata without consideration, 10,496,760 shares of Matinas common stock. Of such shares, 8,931,427 shares were distributed to the Class A Members and the remaining 1,565,333 shares were distributed to the reporting person, the Managing Member of the Class B Member, GJG Capital, LLC."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On June 29, 2017, GJG Life Sciences, LLC distributed to its Members, pro-rata without consideration, 10,496,760 shares of Matinas common stock. Of such shares, 8,931,427 shares were distributed to the Class A Members and the remaining 1,565,333 shares were distributed to the reporting person, the Managing Member of the Class B Member, GJG Capital, LLC."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"On June 29, 2017, GJG Life Sciences, LLC distributed to its Members, pro-rata without consideration, 10,496,760 shares of Matinas common stock. Of such shares, 8,931,427 shares were distributed to the Class A Members and the remaining 1,565,333 shares were distributed to the reporting person, the Managing Member of the Class B Member, GJG Capital, LLC."}],"balance_after":2086576,"source":{"system":"sec-edgar","filing":"0001019056-17-000603","document":"lorenzo_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1697285/000101905617000603/lorenzo_4.xml","form_type":"4"}},{"id":4267679,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":174705,"kind":"person","name":"Lorenzo Jennifer","position":1,"cik":"0001697285","reported_name":"Lorenzo Jennifer","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Shareholder"}},{"id":174706,"kind":"organization","name":"GJG Life Sciences, LLC","position":2,"cik":"0001582638","reported_name":"GJG Life Sciences, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Shareholder"}},{"id":174707,"kind":"organization","name":"GJG Capital, LLC","position":3,"cik":"0001698996","reported_name":"GJG Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Shareholder"}}],"security":"Common Stock","published_at":"2017-07-03T14:02:28.000Z","date":"2017-06-28","kind":"other","acquired":false,"shares":10496760,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By GJG Life Sciences, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 29, 2017, GJG Life Sciences, LLC distributed to its Members, pro-rata without consideration, 10,496,760 shares of Matinas common stock. Of such shares, 8,931,427 shares were distributed to the Class A Members and the remaining 1,565,333 shares were distributed to the reporting person, the Managing Member of the Class B Member, GJG Capital, LLC."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 29, 2017, GJG Life Sciences, LLC distributed to its Members, pro-rata without consideration, 10,496,760 shares of Matinas common stock. Of such shares, 8,931,427 shares were distributed to the Class A Members and the remaining 1,565,333 shares were distributed to the reporting person, the Managing Member of the Class B Member, GJG Capital, LLC."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On June 29, 2017, GJG Life Sciences, LLC distributed to its Members, pro-rata without consideration, 10,496,760 shares of Matinas common stock. Of such shares, 8,931,427 shares were distributed to the Class A Members and the remaining 1,565,333 shares were distributed to the reporting person, the Managing Member of the Class B Member, GJG Capital, LLC."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"On June 29, 2017, GJG Life Sciences, LLC distributed to its Members, pro-rata without consideration, 10,496,760 shares of Matinas common stock. Of such shares, 8,931,427 shares were distributed to the Class A Members and the remaining 1,565,333 shares were distributed to the reporting person, the Managing Member of the Class B Member, GJG Capital, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On June 29, 2017, GJG Life Sciences, LLC distributed to its Members, pro-rata without consideration, 10,496,760 shares of Matinas common stock. Of such shares, 8,931,427 shares were distributed to the Class A Members and the remaining 1,565,333 shares were distributed to the reporting person, the Managing Member of the Class B Member, GJG Capital, LLC."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001019056-17-000603","document":"lorenzo_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697285/000101905617000603/lorenzo_4.xml","form_type":"4"}},{"id":4382557,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":174705,"kind":"person","name":"Lorenzo Jennifer","position":1,"cik":"0001697285","reported_name":"Lorenzo Jennifer","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":174706,"kind":"organization","name":"GJG Life Sciences, LLC","position":2,"cik":"0001582638","reported_name":"GJG Life Sciences, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":174707,"kind":"organization","name":"GJG Capital, LLC","position":3,"cik":"0001698996","reported_name":"GJG Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2017-03-16T10:29:47.000Z","date":"2017-03-15","kind":"other","acquired":false,"shares":1369169,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By GJG Life Sciences, LLC"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"On March 15, 2017 GJG Life Sciences, LLC exercised a warrant to purchase 1,369,169 shares of Matinas common stock at an exercise price of $0.75 a share. The warrant was owned directly by GJG Life Sciences, LLC, a limited liability company of which GJG Capital, LLC is the Managing Member. The reporting person is the Managing Member of GJG Capital, LLC and, as a result, the reporting person and GJG Capital, LLC may be deemed to be indirect beneficial owners of the reported securities. Jennifer Lorenzo and GJG Capital, LLC disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interest. The reporting person is the direct owner of 521,243 shares of Matinas common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On March 15, 2017 GJG Life Sciences, LLC exercised a warrant to purchase 1,369,169 shares of Matinas common stock at an exercise price of $0.75 a share. The warrant was owned directly by GJG Life Sciences, LLC, a limited liability company of which GJG Capital, LLC is the Managing Member. The reporting person is the Managing Member of GJG Capital, LLC and, as a result, the reporting person and GJG Capital, LLC may be deemed to be indirect beneficial owners of the reported securities. Jennifer Lorenzo and GJG Capital, LLC disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interest. The reporting person is the direct owner of 521,243 shares of Matinas common stock."}],"balance_after":0,"derivative":{"exercise_price":0.75,"exercise_date":"2015-04-10","expiration_date":"2020-03-30","underlying":"Common Stock","underlying_shares":1369169},"source":{"system":"sec-edgar","filing":"0001019056-17-000294","document":"lorenzo_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1697285/000101905617000294/lorenzo_4.xml","form_type":"4"}},{"id":4382556,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":174705,"kind":"person","name":"Lorenzo Jennifer","position":1,"cik":"0001697285","reported_name":"Lorenzo Jennifer","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":174706,"kind":"organization","name":"GJG Life Sciences, LLC","position":2,"cik":"0001582638","reported_name":"GJG Life Sciences, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":174707,"kind":"organization","name":"GJG Capital, LLC","position":3,"cik":"0001698996","reported_name":"GJG Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-03-16T10:29:47.000Z","date":"2017-03-15","kind":"other","acquired":true,"shares":1369169,"price":0.75,"value":1026876.75,"ownership":{"direct":false,"nature":"By GJG Life Sciences, LLC"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On March 15, 2017 GJG Life Sciences, LLC exercised a warrant to purchase 1,369,169 shares of Matinas common stock at an exercise price of $0.75 a share. The warrant was owned directly by GJG Life Sciences, LLC, a limited liability company of which GJG Capital, LLC is the Managing Member. The reporting person is the Managing Member of GJG Capital, LLC and, as a result, the reporting person and GJG Capital, LLC may be deemed to be indirect beneficial owners of the reported securities. Jennifer Lorenzo and GJG Capital, LLC disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interest. The reporting person is the direct owner of 521,243 shares of Matinas common stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"On March 15, 2017 GJG Life Sciences, LLC exercised a warrant to purchase 1,369,169 shares of Matinas common stock at an exercise price of $0.75 a share. The warrant was owned directly by GJG Life Sciences, LLC, a limited liability company of which GJG Capital, LLC is the Managing Member. The reporting person is the Managing Member of GJG Capital, LLC and, as a result, the reporting person and GJG Capital, LLC may be deemed to be indirect beneficial owners of the reported securities. Jennifer Lorenzo and GJG Capital, LLC disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interest. The reporting person is the direct owner of 521,243 shares of Matinas common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On March 15, 2017 GJG Life Sciences, LLC exercised a warrant to purchase 1,369,169 shares of Matinas common stock at an exercise price of $0.75 a share. The warrant was owned directly by GJG Life Sciences, LLC, a limited liability company of which GJG Capital, LLC is the Managing Member. The reporting person is the Managing Member of GJG Capital, LLC and, as a result, the reporting person and GJG Capital, LLC may be deemed to be indirect beneficial owners of the reported securities. Jennifer Lorenzo and GJG Capital, LLC disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interest. The reporting person is the direct owner of 521,243 shares of Matinas common stock."}],"balance_after":10496760,"source":{"system":"sec-edgar","filing":"0001019056-17-000294","document":"lorenzo_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697285/000101905617000294/lorenzo_4.xml","form_type":"4"}}]}